Literature DB >> 26965826

Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD.

Arnab Chattopadhyay1, Mohamad Navab1, Greg Hough1, Victor Grijalva1, Pallavi Mukherjee1, Hannah R Fogelman1, Lin H Hwang2, Kym F Faull2, Aldons J Lusis3, Srinivasa T Reddy4, Alan M Fogelman1.   

Abstract

Mouse chow supplemented with lysophosphatidylcholine with oleic acid at sn-1 and a hydroxyl group at sn-2 (LysoPC 18:1) increased LysoPC 18:1 in tissue of the jejunum of LDL receptor (LDLR)-null mice by 8.9 ± 1.7-fold compared with chow alone. Western diet (WD) contained dramatically less phosphatidylcholine 18:1 or LysoPC 18:1 compared with chow, but feeding WD increased LysoPC 18:1 in the jejunum by 7.5 ± 1.4-fold compared with chow. Feeding LysoPC 18:1 or feeding WD increased oxidized phospholipids in the jejunum by 5.2 ± 3.0-fold or 8.6 ± 2.2-fold, respectively, in LDLR-null mice (P < 0.0004), and 2.6 ± 1.5-fold or 2.4 ± 0.92-fold, respectively, in WT C57BL/6J mice (P < 0.0001). Adding 0.06% by weight of a concentrate of transgenic tomatoes expressing the 6F peptide (Tg6F) decreased LysoPC 18:1 in the jejunum of LDLR-null mice on both diets (P < 0.0001), and prevented the increase in oxidized phospholipids in the jejunum in LDLR-null and WT mice on both diets (P < 0.008). Tg6F decreased inflammatory cells in the villi of the jejunum, decreased dyslipidemia, and decreased systemic inflammation in LDLR-null and WT mice on both diets. We conclude that Tg6F reduces diet-induced inflammation by reducing the content of unsaturated LysoPC and oxidized phospholipids in the jejunum of mice.
Copyright © 2016 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  E06 antibody; Western diet; apolipoprotein A-I mimetic peptides; atherosclerosis; lysophosphatidic acid; lysophosphatidylcholine; transgenic tomatoes expressing the 6F peptide

Mesh:

Substances:

Year:  2016        PMID: 26965826      PMCID: PMC4847630          DOI: 10.1194/jlr.M064352

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  43 in total

1.  Jejunum inflammation in obese and diabetic mice impairs enteric glucose detection and modifies nitric oxide release in the hypothalamus.

Authors:  Thibaut Duparc; Damien Naslain; André Colom; Giulio G Muccioli; Nicolas Massaly; Nathalie M Delzenne; Philippe Valet; Patrice D Cani; Claude Knauf
Journal:  Antioxid Redox Signal       Date:  2010-09-29       Impact factor: 8.401

2.  Tomatoes, lysophosphatidic acid, and the small intestine: new pieces in the puzzle of apolipoprotein mimetic peptides?

Authors:  A T Remaley
Journal:  J Lipid Res       Date:  2013-10-21       Impact factor: 5.922

3.  ApoA-I mimetics: tomatoes to the rescue.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  J Lipid Res       Date:  2013-03-07       Impact factor: 5.922

4.  Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.

Authors:  Mohamad Navab; Srinivasa T Reddy; G M Anantharamaiah; Satoshi Imaizumi; Greg Hough; Susan Hama; Alan M Fogelman
Journal:  J Lipid Res       Date:  2011-03-28       Impact factor: 5.922

5.  Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.

Authors:  C Napoli; F P D'Armiento; F P Mancini; A Postiglione; J L Witztum; G Palumbo; W Palinski
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

6.  Oxidized cholesteryl esters and phospholipids in zebrafish larvae fed a high cholesterol diet: macrophage binding and activation.

Authors:  Longhou Fang; Richard Harkewicz; Karsten Hartvigsen; Philipp Wiesner; Soo-Ho Choi; Felicidad Almazan; Jennifer Pattison; Elena Deer; Tiffany Sayaphupha; Edward A Dennis; Joseph L Witztum; Sotirios Tsimikas; Yury I Miller
Journal:  J Biol Chem       Date:  2010-08-14       Impact factor: 5.157

Review 7.  Phospholipase A(2) enzymes in metabolic and cardiovascular diseases.

Authors:  David Y Hui
Journal:  Curr Opin Lipidol       Date:  2012-06       Impact factor: 4.776

8.  Dietary oxidized n-3 PUFA induce oxidative stress and inflammation: role of intestinal absorption of 4-HHE and reactivity in intestinal cells.

Authors:  Manar Awada; Christophe O Soulage; Anne Meynier; Cyrille Debard; Pascale Plaisancié; Bérengère Benoit; Grégory Picard; Emmanuelle Loizon; Marie-Agnès Chauvin; Monique Estienne; Noël Peretti; Michel Guichardant; Michel Lagarde; Claude Genot; Marie-Caroline Michalski
Journal:  J Lipid Res       Date:  2012-08-03       Impact factor: 5.922

9.  High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse.

Authors:  Shengli Ding; Michael M Chi; Brooks P Scull; Rachael Rigby; Nicole M J Schwerbrock; Scott Magness; Christian Jobin; Pauline K Lund
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

10.  Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice.

Authors:  Calum C Bain; Alberto Bravo-Blas; Charlotte L Scott; Elisa Gomez Perdiguero; Frederic Geissmann; Sandrine Henri; Bernard Malissen; Lisa C Osborne; David Artis; Allan McI Mowat
Journal:  Nat Immunol       Date:  2014-08-24       Impact factor: 25.606

View more
  14 in total

1.  Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice.

Authors:  Pallavi Mukherjee; Greg Hough; Arnab Chattopadhyay; Victor Grijalva; Ellen Ines O'Connor; David Meriwether; Alan Wagner; James M Ntambi; Mohamad Navab; Srinivasa T Reddy; Alan M Fogelman
Journal:  J Lipid Res       Date:  2018-08-23       Impact factor: 5.922

2.  Antinociception by the anti-oxidized phospholipid antibody E06.

Authors:  Milad Mohammadi; Beatrice Oehler; Jan Kloka; Corinna Martin; Alexander Brack; Robert Blum; Heike L Rittner
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

3.  The role of the small intestine in modulating metabolism and inflammation in atherosclerosis and cancer.

Authors:  Pallavi Mukherjee; Arnab Chattopadhyay; Alan M Fogelman
Journal:  Curr Opin Lipidol       Date:  2019-10       Impact factor: 4.776

4.  Apolipoprotein A-I mimetics attenuate macrophage activation in chronic treated HIV.

Authors:  William Mu; Madhav Sharma; Rachel Heymans; Eleni Ritou; Valerie Rezek; Philip Hamid; Athanasios Kossyvakis; Shubhendu Sen Roy; Victor Grijalva; Arnab Chattopadhyay; Jeremy Papesh; David Meriwether; Scott G Kitchen; Alan M Fogelman; Srinivasa T Reddy; Theodoros Kelesidis
Journal:  AIDS       Date:  2021-03-15       Impact factor: 4.632

5.  Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial.

Authors:  Richard L Dunbar; Rajesh Movva; LeAnne T Bloedon; Danielle Duffy; Robert B Norris; Mohamad Navab; Alan M Fogelman; Daniel J Rader
Journal:  Clin Transl Sci       Date:  2017-08-09       Impact factor: 4.689

6.  Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation.

Authors:  Beatrice Oehler; Katrin Kistner; Corinna Martin; Jürgen Schiller; Rafaela Mayer; Milad Mohammadi; Reine-Solange Sauer; Milos R Filipovic; Francisco R Nieto; Jan Kloka; Diana Pflücke; Kerstin Hill; Michael Schaefer; Marzia Malcangio; Peter W Reeh; Alexander Brack; Robert Blum; Heike L Rittner
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

7.  Transgenic tomatoes expressing the 6F peptide and ezetimibe prevent diet-induced increases of IFN-β and cholesterol 25-hydroxylase in jejunum.

Authors:  Pallavi Mukherjee; Greg Hough; Arnab Chattopadhyay; Mohamad Navab; Hannah R Fogelman; David Meriwether; Kevin Williams; Steven Bensinger; Travis Moller; Kym F Faull; Aldons J Lusis; M Luisa Iruela-Arispe; Kristina I Bostrom; Peter Tontonoz; Srinivasa T Reddy; Alan M Fogelman
Journal:  J Lipid Res       Date:  2017-06-07       Impact factor: 5.922

8.  Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites.

Authors:  Rongsong Li; Jieping Yang; Arian Saffari; Jonathan Jacobs; Kyung In Baek; Greg Hough; Muriel H Larauche; Jianguo Ma; Nelson Jen; Nabila Moussaoui; Bill Zhou; Hanul Kang; Srinivasa Reddy; Susanne M Henning; Matthew J Campen; Joseph Pisegna; Zhaoping Li; Alan M Fogelman; Constantinos Sioutas; Mohamad Navab; Tzung K Hsiai
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

9.  ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer.

Authors:  Lídia Cedó; Annabel García-León; Lucía Baila-Rueda; David Santos; Victor Grijalva; Melanie Raquel Martínez-Cignoni; José M Carbó; Jari Metso; Laura López-Vilaró; Antonio Zorzano; Annabel F Valledor; Ana Cenarro; Matti Jauhiainen; Enrique Lerma; Alan M Fogelman; Srinivasa T Reddy; Joan Carles Escolà-Gil; Francisco Blanco-Vaca
Journal:  Sci Rep       Date:  2016-11-03       Impact factor: 4.379

10.  Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer.

Authors:  Arnab Chattopadhyay; Xinying Yang; Pallavi Mukherjee; Dawoud Sulaiman; Hannah R Fogelman; Victor Grijalva; Steven Dubinett; Tonya C Wasler; Manash K Paul; Ramin Salehi-Rad; Julia J Mack; M Luisa Iruela-Arispe; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.